Kahn Brothers Group

KAHN BROTHERS GROUP INC · NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗Value Investor
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$601.8M2026 Q3
Positions48
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.76.2%

AUM History

Quarterly History · 40 Quarter

QuarterFiledHoldingsTotal ValueTurnover %Turnover = (value of positions opened + previous value of positions closed + |change in shares| × price for names held in both quarters) / the average portfolio value of the two quarters. Price moves do not count; a quarter with any trade is never 0%.Top 10
2026 Q32026-11-1648$601.8M10.8% C, BAYRY, FLG, GOOG, DIS, Z, MRK, BP, IDT, SEG
2026 Q2✎ amendment applied2026-08-1448$632.7M14.1% C, BAYRY, FLG, GOOG, Z, OGN, DIS, MRK, MBI, SEG
2026 Q12026-05-0848$564.1M21.9% C, BAYRY, FLG, DIS, GOOG, SEB, OGN, BP, MRK, Z
2025 Q42026-02-1254$564.7M3.9% C, BAYRY, FLG, MRK, DIS, GOOG, BP, SEB, OGN, IDT
2025 Q32025-11-1253$531.8M16.9% C, BAYRY, FLG, DIS, OGN, BP, MRK, GOOG, SEB, IDT
2025 Q22025-08-1450$497.9M21.8% C, BAYRY, DIS, FLG, MRK, BP, OGN, IDT, BMY, GSK
2025 Q12025-05-1555$494.5M14.5% C, FLG, MRK, BAYRY, BP, OGN, BMY, DIS, GSK PLC, SEB
2024 Q42025-02-1452$460.4M31.7% C, MRK, DIS, BMY, BP, FLG, GSK PLC, AGO, OGN, BAYRY
2024 Q32024-11-1353$580.6M29.5% C, MRK, BP, NYCBEUR, BAYRY, GSK PLC, BMY, DIS, OGN, PFE
2024 Q22024-08-1452$595.0M19.8% C, MRK, BP, GSK PLC, NYCBEUR, OGN, BMY, BAYRY, MBI, SEB
2024 Q12024-05-1553$674.4M12.8% AGO, MRK, C, BP, GSK PLC, BMY, MBI, PTEN, SEB, PFE
2023 Q42024-02-1343$634.8M4.1% AGO, MRK, NYCBEUR, C, BP, GSK PLC, BMY, PTEN, SEB, VOXX INTERNATIONAL
2023 Q32023-11-1343$640.9M2.6%NYCBEUR, BP, MRK, AGO, PTEN, C, BMY, GSK PLC, SEB, PFE
2023 Q22023-08-0943$682.1M3.8% MRK, NYCBEUR, BP, BMY, AGO, C, PTEN, GSK PLC, MBI, PFE
2023 Q12023-05-1245$694.7M4.8% BP, MRK, BMY, NYCBEUR, AGO, C, PTEN, GSK PLC, MBI, PFE
2022 Q42023-02-1545$759.6M<0.1% AGO, MRK, BP, PTEN, BMY, MBI, PFE, C, NYCBEUR, GSK PLC
2022 Q32022-11-1545$641.7M4.0% BMY, BP, AGO, MRK, PTEN, NYCBEUR, C, PFE, MBI, GSK PLC
2022 Q22022-08-1045$742.7M5.1% PTEN, AGO, BMY, MRK, BP, GSK PLC, MBI, PFE, NYCBEUR, C
2022 Q12022-05-0246$787.6M38.9% PTEN, AGO, MBI, BMY, BP, GSK PLC, MRK, PFE, NYCBEUR, C
2021 Q42022-01-2543$728.0M2.7% MBI, AGO, GSK PLC, PFE, BP, NYCBEUR, BMY, MERCK, CITIGROUP, PTEN
2021 Q32021-11-0143$710.3M4.1% AGO, MBI, BP, NYCBEUR, CITIGROUP, PTEN, MERCK, GSK PLC, BMY, PFE
2021 Q22021-08-0443$698.3M11.2% AGO, CITIGROUP, BMY, PTEN, BP, MERCK, MBI, NYCBEUR, GSK PLC, SEB
2021 Q12021-05-0742$646.1M10.6% AGO, CITIGROUP, NYCBEUR, MERCK, BMY, MBI, BP, GSK PLC, PTEN, SEB
2020 Q42021-02-1142$573.3M10.4% MERCK, BMY, CITIGROUP, AGO, GSK PLC, NYCBEUR, VOXX INTERNATIONAL, BP, MBI, SEB
2020 Q32020-11-0642$527.5M9.3% MERCK, BMY, GSK PLC, NYCBEUR, CITIGROUP, AGO, BP, SEB, MBI, VOXX INTERNATIONAL
2020 Q22020-08-0347$591.8M7.7% MERCK, GSK PLC, BMY, NYCBEUR, CITIGROUP, BP, AGO, SEB, MBI, BB
2020 Q12020-05-1148$546.7M4.0% MERCK, GSK PLC, BMY, NYCBEUR, BP, CITIGROUP, AGO, MBI, SEB, PFE
2019 Q42020-01-2747$824.7M14.3% MERCK, CITIGROUP, AGO, GSK PLC, BMY, NYCBEUR, BP, SEB, MBI, BB
2019 Q3✎ amendment applied2019-11-0448$797.6M51.6% MERCK, CITIGROUP, AGO, NYCBEUR, GSK PLC, BP, SEB, BMY, MBI, BB
2019 Q22019-08-0544$799.9M36.0% MERCK, CITIGROUP, BP, AGO, GSK PLC, SEB, NYCBEUR, MBI, BMY, BB
2019 Q12019-05-0632$640.0M11.5% MERCK, BP, CITIGROUP, AGO, GSK PLC, NYCBEUR, BB, MBI, SEB, BMY
2018 Q42019-01-2931$554.7M3.4% MERCK, BP, CITIGROUP, AGO, GSK PLC, NYCBEUR, MBI, BB, NYT, SEB
2018 Q32018-10-3031$651.2M5.0%CITIGROUP, BP, MERCK, AGO, BB, GSK PLC, MBI, NYCBEUR, NYT, SEB
2018 Q22018-08-0631$628.4M4.6% BP, CITIGROUP, MERCK, GSK PLC, NYT, AGO, BB, MBI, NYCBEUR, SEB
2018 Q12018-05-0131$627.7M6.8%CITIGROUP, BP, NYT, BB, MERCK, GSK PLC, AGO, MBI, SEB, NYCBEUR
2017 Q42018-01-2531$636.6M5.4%CITIGROUP, BP, NYT, MERCK, BB, GSK PLC, AGO, SEB, MBI, PTEN
2017 Q3✎ amendment applied2017-11-0334$654.5M9.9%CITIGROUP, NYT, MERCK, BP, BB, GSK PLC, MBI, SEB, AGO, VOXX INTERNATIONAL
2017 Q22017-08-0834$655.8M8.7%CITIGROUP, NYT, MERCK, BP, GSK PLC, BB, MBI, HO1, SEB, AGO
2017 Q12017-05-0835$581.4M9.7%CITIGROUP, MERCK, NYT, BP, GSK PLC, HO1, MBI, BB, SEB, NYCBEUR
2016 Q42017-01-3135$592.1M30.6%CITIGROUP, MERCK, NYT, BP, HO1, MBI, NYCBEUR, SEB, GSK PLC, BB

Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".

Related managers

Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.